Boehringer Ingelheim International GmbH

Allemagne


Commandez votre montre hebdomadaire Boehringer Ingelheim International GmbH
Quantité totale PI 4 636
Quantité totale incluant filiales 4 638 (+ 8 pour les filiales)
Rang # Quantité totale PI 246
Note d'activité PI 4/5.0    2 057
Rang # Activité PI 327
Parent C.H. Boehringer Sohn AG & Co. KG
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

1 341 429
353 321
1 493 643
56
 
Dernier brevet 2025 - Dual glp-1 and glucagon receptor...
Premier brevet 1980 - Method of eliminating opiate wit...
Dernière marque 2025 - DETECT THE SOS
Première marque 1965 - PERSANTINE

Filiales

4 subsidiaries with IP (8 patents, 0 trademarks)

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Providing a website featuring information in the field of cardiovascular, kidney and metabolic he...
P/S Education services, namely, providing workshops, seminars, and training sessions on medical care ...
P/S Organization and conducting of workshops, seminars, and training sessions on medical care and hea...
P/S Scientific research in the field of treatment of diseases resulting from genetic disorders; provi...
P/S Scientific research in the field of prevention and treatment of diseases resulting from metaboli...
P/S Scientific research in the field of treatment of diseases resulting from genetic disorders; prov...
P/S Scientific research in the field of prevention and treatment of diseases resulting from metabolic...
P/S Medical and scientific research in the fields of respiratory, inflammatory and autoimmune disease...
P/S Medical and scientific research in the fields of respiratory, inflammatory and autoimmune diseas...
P/S Pharmaceutical preparations.
Invention Method for membrane gas transfer in high density bioreactor culture. The present invention provi...
P/S Scientific research in the field of prevention and treatment of metabolic and cardiovascular dise...
P/S Scientific research in the field of prevention and treatment of cardiovascular diseases; providin...
P/S Scientific research in the field of prevention and treatment of metabolic and cardiovascular dis...
P/S Scientific research in the field of prevention and treatment of cardiovascular diseases; providi...
Invention Pyridine derivatives with n-linked cyclic substituents as cgas inhibitors. The invention relates...
Invention Pharmaceutical composition, methods for treating and uses thereof. The present invention relates...
P/S Downloadable and recorded software for providing information on clinical trials Promoting public ...
Invention Bioreactor or fermenter for the culturing of cells or microorganisms in suspension in industrial ...
Invention Glucagon analogues as long-acting glp-1/glucagon receptor agonists in the treatment of fatty live...
P/S Organization and implementation of workshops, seminars, and training courses in the field of ment...
P/S Organization and implementation of workshops, seminars, and training courses in the field of men...
Invention Heterologous prime boost vaccine. The present invention pertains to the provision of a vaccine c...
P/S Scientific research in the field of prevention and treatment of retinal diseases and diabetic ey...
P/S Scientific research in the field of prevention and treatment of retinal diseases and diabetic eye...
P/S Scientific research in the field of medicine; providing medical and scientific research informati...
Invention Crystalline forms of a her2 tyrosine kinase inhibitor. The present invention relates to crystall...
P/S Downloadable computer software applications for assisting patients with the management of symptom...
Invention Dual glp-1 and glucagon receptor agonist for the treatment of mash and cirrhosis. HNH22 2 .
Invention Avenciguat for use in the treatment of chronic kidney disease and screening method for predicting...
Invention Compound for use in the treatment of depression, obsessive-compulsive disorder, post-traumatic st...
Invention Benzimidazole derivatives as cgas inhibitors. The invention relates to compounds of formula (I), ...
Invention Monoarylic heterocyclic compounds as sting antagonists and the use thereof as medicament. This in...
Invention Monoaryl and hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use th...
Invention Heterocyclic acids as sting antagonists and the use thereof as medicament. This invention relates...
Invention Hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medi...
Invention Further heterocyclic compounds as sting antagonists and the use thereof as medicament. This inven...
Invention Arylamide substituted indazoles and the use thereof as medicament. This invention relates to comp...
Invention Novel bicyclic benzylamido pyridine derivatives as sos1 inhibitors. The present invention encomp...
Invention Bicyclic benzylamido pyridine derivatives as sos1 inhibitors. The present invention encompasses c...
Invention Combination of zongertinib with a sos1 inhibitor for use in the treatment of cancer. The present ...
P/S Medical and scientific research in the fields of respiratory diseases, inflammatory diseases and ...
P/S Medical and scientific research in the fields of respiratory diseases, inflammatory diseases and...
P/S Downloadable computer software and downloadable mobile applications for assisting patients with s...
P/S Downloadable computer software and downloadable mobile applications for assisting patients with ...
Invention Aldosterone synthase inhibitor for treating heart failure. Disclosed are methods of using an aldo...
P/S Organization and conducting of workshops, seminars and training courses for medical care, prevent...
P/S Organization and conducting of workshops, seminars and training courses for medical care, preven...
Invention Antibodies to connective tissue growth factor (ctgf) and uses thereof. The present disclosure gen...
Invention Antibodies to connective tissue growth factor (ctgf) and uses thereof. The present disclosure ge...
Invention Solid forms of an aldosterone synthase inhibitor. Disclosed are solid forms of an inhibitor of al...
Invention Solid forms of an aldosterone synthase inhibitor. Disclosed are solid forms of an inhibitor of a...
P/S Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the ali...
Invention Piperidinylphenylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase an...
Invention Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase...
Invention Piperidinylbenzonitrile derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glut...
Invention Combination of active agents for the treatment of progressive fibrosing interstitial lung disease...
Invention 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament. Disclosed are 4-p...
Invention Assays for screening and validation of inhibitors of a-to-i rna editing enzymes. The present inve...
2024 Invention Anti-c3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocula...
Invention Combination treatment for eye fibrosis and/or angiogenesis. Methods for the diagnosis, treatment...
Invention Anti-cancer combination therapy. The present invention refers to the combination of the HER2 tyr...
Invention Novel synthetic steps for the manufacturing method of the pde4b-inhibitor 1-({(5r)-2-[4-(5-chloro...
Invention C-type natriuretic peptide engrafted antibodies. The present invention relates to an antibody or...
Invention Methods of treating inflammatory diseases. This invention generally relates to methods for the t...
Invention Treatment for diabetes in patients inappropriate for metformin therapy. The present invention re...
2023 Invention Hsd17b13 inhibitors. The present invention encompasses heteroaryl substituted 2,6-difluorophenol...
Invention Recombinant expression of myeloid-derived growth factor. The present invention generally relates...
Invention New glutamine synthetase variants as selection marker. The invention relates to a modified mamma...
Invention Spiro[3h-indole-3,2′-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors. The ...
2022 Invention Dose regimen for long-acting glp1/glucagon receptor agonists. The present invention relates to a...
2021 Invention Viral capsid proteins with specificity to heart tissue cells. This invention generally relates t...